Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitri M Drekonja

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2011
Vancomycin "telephone"Dimitri M Drekonja
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 23, 2009
Noninferiority of linezolid for skin and bloodstream infectionsDimitri M Drekonja
Infectious Disease Clinics of North America|April 4, 2024
Urinary Tract Infection in Male Patients: Challenges in ManagementDimitri M Drekonja
Infection Control and Hospital Epidemiology|October 9, 2010
Rifampin plus metronidazole for Clostridium difficile infectionDimitri M Drekonja
Journal of Comparative Effectiveness Research|October 29, 2014
Clostridium difficile infection: current, forgotten and emerging treatment optionsDimitri M Drekonja
Diagnostic Microbiology and Infectious Disease|August 31, 2013
Erysipelothrix bacteremia without endocarditis: rare event or under-reported occurrence?Dimitri M Drekonja
Annals of Surgery|May 9, 2012
Metronidazole therapy to prevent clostridium difficile infectionDimitri M Drekonja
JAMA Internal Medicine|June 26, 2013
Time to redefine the duration of antimicrobial treatment in male patients with urinary infections--replyDimitri M Drekonja
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|May 9, 2024
<i>Clostridioides difficile</i> infection in trials of short versus long duration of antimicrobialsDimitri M Drekonja, Peyton Smith
Health Affairs (Project Hope)|June 5, 2018
Identifying Antibiotic-Resistant InfectionsDimitri M Drekonja, James R Johnson
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2011
Vancomycin "telephone"Dimitri M Drekonja
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 23, 2009
Noninferiority of linezolid for skin and bloodstream infectionsDimitri M Drekonja
Infectious Disease Clinics of North America|April 4, 2024
Urinary Tract Infection in Male Patients: Challenges in ManagementDimitri M Drekonja
Infection Control and Hospital Epidemiology|October 9, 2010
Rifampin plus metronidazole for Clostridium difficile infectionDimitri M Drekonja
Journal of Comparative Effectiveness Research|October 29, 2014
Clostridium difficile infection: current, forgotten and emerging treatment optionsDimitri M Drekonja
Diagnostic Microbiology and Infectious Disease|August 31, 2013
Erysipelothrix bacteremia without endocarditis: rare event or under-reported occurrence?Dimitri M Drekonja
Annals of Surgery|May 9, 2012
Metronidazole therapy to prevent clostridium difficile infectionDimitri M Drekonja
JAMA Internal Medicine|June 26, 2013
Time to redefine the duration of antimicrobial treatment in male patients with urinary infections--replyDimitri M Drekonja
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|May 9, 2024
<i>Clostridioides difficile</i> infection in trials of short versus long duration of antimicrobialsDimitri M Drekonja, Peyton Smith
Health Affairs (Project Hope)|June 5, 2018
Identifying Antibiotic-Resistant InfectionsDimitri M Drekonja, James R Johnson
Pageof 5